Effect of nutrition on plasma C-type natriuretic peptide forms in adult sheep: evidence for enhanced C-type natriuretic peptide degradation during caloric restriction

Metabolism: Clinical and Experimental

Volumn 59, Issue 6, 2010, Pages 796-801

  Prickett, Timothy C R ^a   Ryan, John F ^a   Wellby, Martin ^b   Barrell, Graham K ^b   Yandle, Timothy G ^a   Richards, A Mark ^a   Espiner, Eric A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b LINCOLN UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; NATRIURETIC PEPTIDE TYPE C; UREA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BONE GROWTH; CALORIC RESTRICTION; CONTROLLED STUDY; ENERGY METABOLISM; EWE; FEMALE; GROWTH PLATE; NONHUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OSSIFICATION; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UREA BLOOD LEVEL; WEIGHT CHANGE;

ALKALINE PHOSPHATASE; ANIMALS; BLOOD GLUCOSE; CALORIC RESTRICTION; ENERGY INTAKE; FEMALE; INSULIN-LIKE GROWTH FACTOR I; LIVER; NATRIURETIC PEPTIDE, C-TYPE; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; ORGAN SIZE; RADIOIMMUNOASSAY; SHEEP; UREA;

EID: 77952252492     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.09.026     Document Type: Article

References (41)

1. Potter L.R., Abbey-Hosch S., and Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endoc Rev 27 (2006) 47-72
2. Minamino N., Aburaya M., Kojima M., Miyamoto K., Kangawa K., and Matsuo H. Distribution of C-type natriuretic peptide and its messenger RNA in rat central nervous system and peripheral tissue. Biochem Biophys Res Commun 197 (1993) 326-335
3. Heublein D.M., Clavell A.L., Stingo A.J., Lerman A., Wold L., and Burnett J.C. C-type natriuretic peptide immunoreactivity in human breast vascular endothelial cells. Peptides 13 (1992) 1017-1019
4. Yasoda A., Ogawa Y., Suda M., Tamura N., Mori K., Sakuma Y., et al. Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway. J Biol Chem 273 (1998) 11695-11700
5. Suda M., Ogawa Y., Tanaka K., Tamura N., Yasoda A., Takigawa T., et al. Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. Proc Natl Acad Sci U S A 95 (1998) 2337-2342
6. Cao L., and Gardner D.G. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension 25 (1995) 227-234
7. Chusho H., Tamura N., Ogawa Y., Yasoda A., Suda M., Miyazawa T., et al. Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci U S A 98 (2001) 4016-4021
8. Jiao Y., Yan J., Jiao F., Yang H., Donahue L.R., Li X., et al. A single nucleotide mutation in Nppc is associated with a long bone abnormality in lbab mice. BMC Genetics 8 (2007) 16
9. Tamura N., Doolittle L.K., Hammer R.E., Shelton J.M., Richardson J.A., and Garbers D.L. Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs. Proc Natl Acad Sci U S A 101 (2004) 17300-17305
10. Bartels C.F., Bukulmez H., Padayatti P., Rhee D.K., van Ravenswaaij-Arts C., Pauli R.M., et al. Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am J Hum Genet 75 (2004) 27-34
11. Yasoda A., Komatsu Y., Chusho H., Miyazawa T., Ozasa A., Miura M., et al. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat Med 10 (2004) 80-86
12. Matsukawa N., Grzesik W.J., Takahashi N., Pandey K.N., Pang S., Yamauchi M., et al. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci U S A 96 (1999) 7403-7408
13. Miyazawa T., Ogawa Y., Chusho H., Yasoda A., Tamura N., Komatsu Y., et al. Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification. Endocrinology 143 (2002) 3604-3610
14. Prickett T.C.R., Lynn A.M., Barrell G.K., Darlow B.A., Cameron V.A., Espiner E.A., et al. Amino-terminal proCNP: a putative marker of cartilage activity in postnatal growth. Pediatr Res 58 (2005) 334-340
15. Prickett T.C., Barrell G.K., Wellby M., Yandle T.G., Richards A.M., and Espiner E.A. Response of plasma CNP forms to acute anabolic and catabolic interventions in growing lambs. Am J Physiol. Endocrinol Metab 292 (2007) E1395-E1400
16. Prickett T.C., Rumball C.W., Buckley A.J., Bloomfield F.H., Yandle T.G., Harding J.E., et al. C-type natriuretic peptide forms in the ovine fetal and maternal circulations: evidence for independent regulation and reciprocal response to undernutrition. Endocrinology 148 (2007) 4015-4022
17. Breier B.H., Milsom S.R., Blum W.F., Schwander J., Gallaher B.W., and Gluckman P.D. Insulin-like growth factors and their binding proteins in plasma and milk after growth hormone-stimulated galactopoiesis in normally lactating women. Acta Endocrinologica 129 (1993) 427-435
18. Prickett T.C.R., Yandle T.G., Nicholls M.G., Espiner E.A., and Richards A.M. Identification of amino-terminal pro-C-type natriuretic peptide in human plasma. Biochem Biophys Res Commun 286 (2001) 513-517
19. Yandle T.G., Fisher S., Charles C., Espiner E.A., and Richards A.M. The ovine hypothalamus and pituitary have markedly different distributions of C-type natriuretic peptide forms. Peptides 14 (1993) 713-716
20. Wu C., Wu F., Pan J., Morser J., and Wu Q. Furin-mediated processing of pro-C-type natriuretic peptide. J Biol Chem 278 (2003) 25847-25852
21. Kenny A.J., Bourne A., and Ingram J. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11. Biochemi J 291 (1993) 83-88
22. Suga S., Nakao K., Hosoda K., Mukoyama M., Ogawa Y., Shirakami G., et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130 (1992) 229-239
23. Thibault G., Lacasse A., and Garcia R. Specific potentiation by cyclic AMP of natriuretic peptide-mediated cyclic GMP production in adipose tissue. Life Sci 58 (1996) 2345-2353
24. Sarzani R., Paci V.M., Zingaretti C.M., Pierleoni C., Cinti S., Cola G., et al. Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue. J Hypertens 13 (1995) 1241-1246
25. Hunt P.J., Espiner E.A., Richards A.M., Yandle T.G., Frampton C., and Nicholls M.G. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men. Am J Physiol 269 (1995) R1397-R1403
26. Charles C.J., Espiner E.A., Richards A.M., Nicholls M.G., and Yandle T.G. Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep. Am J Physiol Regul Integr Comp Physiol 270 (1996) R1324-R1331
27. Pham I., Sediame S., Maistre G., Roudot-Thoraval F., Chabrier P.E., Carayon A., et al. Renal and vascular effects of C-type and atrial natriuretic peptides in humans. Am J Physiol 273 (1997) R1457-R1464
28. Dessi-Fulgheri P., Sarzani R., Serenelli M., Tamburrini P., Spagnolo D., Giantomassi L., et al. Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives. Hypertension 33 (1999) 658-662
29. Starklint J., Bech J.N., and Pedersen E.B. Down-regulation of urinary AQP2 and unaffected response to hypertonic saline after 24 hours of fasting in humans. Kidney Int 67 (2005) 1010-1018
30. Hunt L.M., Hogeland E.W., Henry M.K., and Swoap S.J. Hypotension and bradycardia during caloric restriction in mice are independent of salt balance and do not require ANP receptor. Am J Physiol Heart Circ Physiol 287 (2004) H1446-H1451
31. Messaoudi L., Donckier J., Stoffel M., Ketelslegers J.M., and Kolanowski J. Changes in blood pressure and in vasoactive and volume regulatory hormones during semistarvation in obese subjects. Metabolism 47 (1998) 592-597
32. Crandall D.L., Ferraro G.D., and Cervoni P. Effect of experimental obesity and subsequent weight reduction upon circulating atrial natriuretic peptide. Proc Soc Exp Biol Med 191 (1989) 352-356
33. Maoz E., Shamiss A., Peleg E., Salzberg M., and Rosenthal T. The role of atrial natriuretic peptide in natriuresis of fasting. J Hypertens 10 (1992) 1041-1044
34. Thomas G., Moffatt P., Salois P., Gaumond M.H., Gingras R., Godin E., et al. Osteocrin, a novel bone-specific secreted protein that modulates the osteoblast phenotype. J Biol Chem 278 (2003) 50563-50571
35. Moffatt P., Thomas G., Sellin K., Bessette M.C., Lafreniere F., Akhouayri O., et al. Osteocrin is a specific ligand of the natriuretic peptide clearance receptor that modulates bone growth. J Biol Chem 282 (2007) 36454-36462
36. Bord S., Ireland D.C., Moffatt P., Thomas G.P., and Compston J.E. Characterization of osteocrin expression in human bone. J Histochem Cytochem 53 (2005) 1181-1187
37. Nishizawa H., Matsuda M., Yamada Y., Kawai K., Suzuki E., Makishima M., et al. Musclin, a novel skeletal muscle-derived secretory factor. J Biol Chem 279 (2004) 19391-19395
38. Grinspoon S.K., Baum H.B., Peterson S., and Klibanski A. Effects of rhIGF-I administration on bone turnover during short-term fasting. J Clin Invest 96 (1995) 900-906
39. Farnum C.E., Lee A.O., O'Hara K., and Wilsman N.J. Effect of short-term fasting on bone elongation rates: an analysis of catch-up growth in young male rats. Pediatr Res 53 (2003) 33-41
40. Hunt P.J., Richards A.M., Espiner E.A., Nicholls M.G., and Yandle T.G. Bioactivity and metabolism of C-type natriuretic peptide in normal man. J Clin Endocrinol Metab 78 (1994) 1428-1435
41. Lafontan M., and Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 48 (2009) 275-297